Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
13.58
-0.12 (-0.88%)
At close: Jul 11, 2025, 4:00 PM
13.55
-0.03 (-0.22%)
After-hours: Jul 11, 2025, 7:00 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Laboratory Solutions | 4.61B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Laboratory Solutions Growth | -3.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Bioscience Production | 2.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Bioscience Production Growth | -0.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Proprietary Materials & Consumables | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Proprietary Materials & Consumables Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Third Party Materials & Consumables | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Third Party Materials & Consumables Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Services & Specialty Procurement | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Services & Specialty Procurement Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Equipment & Instrumentation | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Equipment & Instrumentation Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capex by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2018 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2018 |
Americas Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
AMEA Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
AMEA Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBITDA by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2018 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2018 |
Americas Adjusted EBITDA |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas Adjusted EBITDA Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Adjusted EBITDA |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Adjusted EBITDA Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
AMEA Adjusted EBITDA |
Log In |
Log In |
Log In |
Log In | Upgrade
|
AMEA Adjusted EBITDA Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Adjusted EBITDA |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Adjusted EBITDA Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2018 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2018 |
Americas |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
AMEA |
Log In |
Log In |
Log In |
Log In | Upgrade
|
AMEA Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Laboratory Solutions Adjusted Operating Income | 598.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Laboratory Solutions Adjusted Operating Income Growth | -6.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Bioscience Production Adjusted Operating Income | 558.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Bioscience Production Adjusted Operating Income Growth | -2.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Adjusted Operating Income | -66.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Adjusted Operating Income Growth | 17.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|